Respiratory virus-induced EGFR activation suppresses IRF1-dependent interferon λ and antiviral defense in airway epithelium.

Inhibition of epidermal growth factor receptor during viral infection augments IRF1-dependent IFN-λ production and decreases viral titers.

[1]  L. Touqui,et al.  Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway. , 2012, American journal of respiratory cell and molecular biology.

[2]  G. Gallagher,et al.  Regulation of IFN-λ1 Promoter Activity (IFN-λ1/IL-29) in Human Airway Epithelial Cells , 2011, The Journal of Immunology.

[3]  Naveen Kumar,et al.  Receptor Tyrosine Kinase Inhibitors That Block Replication of Influenza A and Other Viruses , 2011, Antimicrobial Agents and Chemotherapy.

[4]  Adolfo García-Sastre,et al.  Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway , 2011, PLoS pathogens.

[5]  Yuying Liang,et al.  Receptor Tyrosine Kinase Inhibitors Block Multiple Steps of Influenza A Virus Replication , 2011, Journal of Virology.

[6]  J. Shively,et al.  Regulation of CEACAM1 transcription in human breast epithelial cells , 2010, BMC Molecular Biology.

[7]  D. Proud,et al.  Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1. , 2010, American journal of respiratory cell and molecular biology.

[8]  R. Fouchier,et al.  The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells , 2010, PLoS pathogens.

[9]  S. Smirnov,et al.  Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo , 2010, Journal of Virology.

[10]  S. Johnston,et al.  Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-&kgr;B and EGFR pathways , 2010, European Respiratory Journal.

[11]  S. Günther,et al.  Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections , 2010, Journal of Virology.

[12]  David J. Miller,et al.  Role of Double-Stranded RNA Pattern Recognition Receptors in Rhinovirus-Induced Airway Epithelial Cell Responses1 , 2009, The Journal of Immunology.

[13]  J. Alcorn,et al.  Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.

[14]  Wai-ming Lee,et al.  Rhinovirus-induced Major Airway Mucin Production Involves a Novel Tlr3-egfr–dependent Pathway , 2009 .

[15]  S. Johnston,et al.  Respiratory virus induction of alpha‐, beta‐ and lambda‐interferons in bronchial epithelial cells and peripheral blood mononuclear cells , 2009, Allergy.

[16]  K. Hartshorn,et al.  Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-λ1) in Response to Influenza A Infection1 , 2009, The Journal of Immunology.

[17]  P. Burgel,et al.  Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases , 2008, European Respiratory Journal.

[18]  J. Nadel,et al.  Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[19]  M. Hibbs,et al.  Epidermal Growth Factor Receptor Signaling to Erk1/2 and STATs Control the Intensity of the Epithelial Inflammatory Responses to Rhinovirus Infection* , 2008, Journal of Biological Chemistry.

[20]  T. Taniguchi,et al.  The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.

[21]  Eun Joo Lee,et al.  Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation , 2007, Experimental & Molecular Medicine.

[22]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[23]  G. Hunninghake,et al.  Activation of the Epidermal Growth Factor Receptor by Respiratory Syncytial Virus Results in Increased Inflammation and Delayed Apoptosis* , 2005, Journal of Biological Chemistry.

[24]  J. Nadel,et al.  Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Nadel,et al.  Tumor necrosis factor α-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Proud,et al.  Effects of tumor necrosis factor-α, epidermal growth factor and transforming growth factor-α on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells , 2001 .

[27]  D. Proud,et al.  Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. , 1995, The Journal of clinical investigation.

[28]  A. Choi,et al.  Influenza virus A infection induces interleukin‐8 gene expression in human airway epitheial cells , 1992 .

[29]  H. Ellerbrok,et al.  Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa). , 2011, Antiviral research.

[30]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[31]  S. Johnston.  Overview of virus-induced airway disease. , 2005, Proceedings of the American Thoracic Society.

[32]  D. Proud,et al.  Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells. , 2001, International immunopharmacology.

[33]  A. Choi,et al.  Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. , 1992, FEBS letters.